2016
DOI: 10.1016/j.diagmicrobio.2016.03.017
|View full text |Cite
|
Sign up to set email alerts
|

A screening algorithm for diagnosing bacterial gastroenteritis by real-time PCR in combination with guided culture

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
30
0

Year Published

2016
2016
2022
2022

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 27 publications
(33 citation statements)
references
References 21 publications
3
30
0
Order By: Relevance
“…Similarly, 100% sensitivity was reported for bone marrow samples that tested positive for Salmonella (125), and successful results (95.4% sensitivity) have also been reported for the efficacy of nested PCR targeting the flagellin gene (fliC) to detect S. Typhi in urine (126) and blood (127) samples. Other useful Salmonella-specific genes that were used for Salmonella detection in clinical samples include the S. Typhi Vi capsular gene viaB (128), hilA (a regulatory gene controlling the expression of SPI-1 genes) (129), the tetrathionate genes ttrC-ttrA (130,131), the 23S rRNA gene (132), and the CS54 island-borne gene ratA (133).…”
Section: Pcr-based Molecular Methods For Salmonella Detectionmentioning
confidence: 99%
“…Similarly, 100% sensitivity was reported for bone marrow samples that tested positive for Salmonella (125), and successful results (95.4% sensitivity) have also been reported for the efficacy of nested PCR targeting the flagellin gene (fliC) to detect S. Typhi in urine (126) and blood (127) samples. Other useful Salmonella-specific genes that were used for Salmonella detection in clinical samples include the S. Typhi Vi capsular gene viaB (128), hilA (a regulatory gene controlling the expression of SPI-1 genes) (129), the tetrathionate genes ttrC-ttrA (130,131), the 23S rRNA gene (132), and the CS54 island-borne gene ratA (133).…”
Section: Pcr-based Molecular Methods For Salmonella Detectionmentioning
confidence: 99%
“…As these tests become more prevalent in clinical microbiology laboratories, it is essential that adequate evaluation of molecular tests for the diagnosis of gastrointestinal infections is undertaken. Recent evaluation studies demonstrate that the use of molecular-based diagnostics increases the sensitivity of testing for some enteric pathogens, with overall high negative predictive values [4][5][6][7][8][9][10]. However, the UK National Institute for Health and Care Excellence (NICE) published their diagnostics guidance in January 2017 [11], based on a Diagnostic Assessment Report commissioned by the National Institute of Health Research (NIHR) Health Technology Assessment (HTA) Programme [12].…”
Section: Evidence To Support Molecular-based Diagnostic Testingmentioning
confidence: 99%
“…The introduction of molecular technologies into a clinical microbiology laboratory, such as multiplex polymerase chain reaction (PCR) assays, can benefit the diagnosis of gastrointestinal infection by facilitating simultaneous detection of pathogens (bacterial, parasitic and viral) directly from faeces. Molecular-based diagnosis gives a laboratory the potential to increase sample throughput, increase the amount of information obtained from a single test and decrease sample turnaround times [4][5][6][7][8][9][10]. Additionally, simple workflows and a reduction in the need for technical expertise are appealing attributes of these diagnostic methods.…”
Section: Introductionmentioning
confidence: 99%
“…The sensitivity of the culturing of Shigella spp. and EIEC is low [12]. Additionally, most laboratories perform a molecular prescreening based on the ipaH gene, which is present in both Shigella spp and EIEC.…”
Section: Introductionmentioning
confidence: 99%
“…Additionally, most laboratories perform a molecular prescreening based on the ipaH gene, which is present in both Shigella spp and EIEC. From approximately half of fecal samples positive in the molecular prescreening an isolate cannot be obtained in culture [12,13]. Shigellosis cases that are diagnosed purely by molecular procedures are not notifiable.…”
Section: Introductionmentioning
confidence: 99%